ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,361,000 | -34.4% | 3,197,712 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $2,076,000 | -79.4% | 3,197,712 | 0.0% | 0.00% | -80.0% |
Q3 2016 | $10,073,000 | +1.9% | 3,197,712 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $9,881,000 | -14.6% | 3,197,712 | 0.0% | 0.01% | -16.7% |
Q1 2016 | $11,576,000 | -8.2% | 3,197,712 | +17.6% | 0.01% | 0.0% |
Q4 2015 | $12,612,000 | -18.9% | 2,718,012 | +6.4% | 0.01% | -25.0% |
Q3 2015 | $15,557,000 | -21.8% | 2,554,512 | +10.7% | 0.01% | -11.1% |
Q2 2015 | $19,891,000 | +92.8% | 2,307,512 | 0.0% | 0.01% | +80.0% |
Q1 2015 | $10,315,000 | +380.9% | 2,307,512 | +69.9% | 0.01% | +400.0% |
Q4 2014 | $2,145,000 | +15.9% | 1,357,812 | +40.9% | 0.00% | 0.0% |
Q3 2014 | $1,851,000 | -43.4% | 963,912 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $3,268,000 | +20.3% | 963,912 | +18.9% | 0.00% | 0.0% |
Q1 2014 | $2,716,000 | +9.1% | 810,812 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $2,489,000 | -11.0% | 810,812 | +16.5% | 0.00% | 0.0% |
Q3 2013 | $2,797,000 | – | 695,712 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,431,196 | $2,748,000 | 1.18% |
Abingworth LLP | 437,994 | $832,000 | 0.50% |
Broadfin Capital, LLC | 1,301,622 | $2,499,000 | 0.26% |
Rhenman & Partners Asset Management AB | 400,000 | $768,000 | 0.22% |
BVF INC/IL | 559,624 | $1,074,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $3,248,000 | 0.12% |
Perceptive Advisors | 478,456 | $919,000 | 0.10% |
Gruss Capital Management LP | 1,720,000 | $3,302,000 | 0.08% |
SECTORAL ASSET MANAGEMENT INC | 247,961 | $476,000 | 0.02% |
Spark Investment Management LLC | 36,400 | $69,000 | 0.01% |